{"title":"Articles of Significant Interest Selected from This Issue by the Editors","authors":"","doi":"10.1128/cvi.00233-17","DOIUrl":null,"url":null,"abstract":"Escherichia coli K1 strains are a major cause of neonatal sepsis and meningitis and are associated with poor clinical outcome. They colonize the gastrointestinal tract of the newborn infant before translocation to the blood by poorly defined mechanisms. McCarthy et al. (p. 3704 –3711) show that colibactin, a genotoxin that causes genetic instability in eukaryotic cells, is widely distributed amongst E. coli K1 isolates, is required for optimal gastrointestinal colonization, and facilitates entry into the bloodstream of neonatal rats. They demonstrate for the first time that colibactin makes a significant contribution to invasive neonatal disease and may be a target for therapeutic intervention.","PeriodicalId":10271,"journal":{"name":"Clinical and Vaccine Immunology","volume":"2020 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Vaccine Immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1128/cvi.00233-17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0
Abstract
Escherichia coli K1 strains are a major cause of neonatal sepsis and meningitis and are associated with poor clinical outcome. They colonize the gastrointestinal tract of the newborn infant before translocation to the blood by poorly defined mechanisms. McCarthy et al. (p. 3704 –3711) show that colibactin, a genotoxin that causes genetic instability in eukaryotic cells, is widely distributed amongst E. coli K1 isolates, is required for optimal gastrointestinal colonization, and facilitates entry into the bloodstream of neonatal rats. They demonstrate for the first time that colibactin makes a significant contribution to invasive neonatal disease and may be a target for therapeutic intervention.
期刊介绍:
Cessation. First launched as Clinical and Diagnostic Laboratory Immunology (CDLI) in 1994, CVI published articles that enhanced the understanding of the immune response in health and disease and after vaccination by showcasing discoveries in clinical, laboratory, and vaccine immunology. CVI was committed to advancing all aspects of vaccine research and immunization, including discovery of new vaccine antigens and vaccine design, development and evaluation of vaccines in animal models and in humans, characterization of immune responses and mechanisms of vaccine action, controlled challenge studies to assess vaccine efficacy, study of vaccine vectors, adjuvants, and immunomodulators, immune correlates of protection, and clinical trials.